igf 1 lr3 cancer risk IGF-1 Research: Extended Half-Life Drugging IGF-1R in cancer: New
Drugging IGF 1R in cancer: New insights and emerging opportunities ScienceDirect Recent update on IGF 1 IGF 1R signaling axis as a promising therapeutic target for triple negative breast cancer ScienceDirect Insulin Like Growth Factor 1 (IGF 1) and Its Monitoring in Medical Diagnostic and in Sports Dietary and pharmacological modification of the insulin IGF 1 system: exploiting the full repertoire against cancer Oncogenesis
Pay in 4 interest-free payments of $6.98 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 16 - Sep 21



